Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
20.96
+0.71 (3.51%)
At close: Jun 26, 2026, 4:00 PM EDT
21.17
+0.21 (0.98%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Adaptive Biotechnologies stock have an average target of 20.17, with a low estimate of 18 and a high estimate of 22. The average target predicts a decrease of -3.77% from the current stock price of 20.96.
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 16, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $18 | Hold | Maintains | $21 → $18 | -14.12% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | -4.58% | May 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $21 → $19 | Buy | Reiterates | $21 → $19 | -9.35% | May 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $21 | Buy | Reiterates | $21 | +0.19% | May 6, 2026 |
Financial Forecast
Revenue This Year
287.25M
from 276.98M
Increased by 3.71%
Revenue Next Year
352.11M
from 287.25M
Increased by 22.58%
EPS This Year
-0.46
from -0.39
EPS Next Year
-0.25
from -0.46
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 290.4M | 357.2M | |
| Avg | 287.2M | 352.1M | |
| Low | 284.1M | 347.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.8% | 24.4% | |
| Avg | 3.7% | 22.6% | |
| Low | 2.6% | 21.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.43 | -0.17 | |
| Avg | -0.46 | -0.25 | |
| Low | -0.48 | -0.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.